Creating a virtual reality platform for remote rehabilitation of patients with rare diseases
Immersive and Interactive VR Platform for Quantitative Telehealth Rehabilitation of Rare Diseases
['FUNDING_OTHER'] · ALTEC, INC. · NIH-10948130
This study is testing a new virtual reality program that helps doctors provide rehabilitation therapy for patients with rare diseases from home, making it easier for you to stay engaged and get personalized support while tracking your progress.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | ALTEC, INC. (nih funded) |
| Locations | 1 site (NATICK, UNITED STATES) |
| Trial ID | NIH-10948130 on ClinicalTrials.gov |
What this research studies
This research aims to develop an immersive virtual reality (VR) platform that allows healthcare providers to conduct rehabilitation therapy for patients with rare diseases from a distance. By utilizing this technology, physicians can guide therapy sessions while simultaneously collecting important health metrics to monitor patient progress. The approach focuses on enhancing patient engagement and providing tailored rehabilitation experiences that can be accessed from home. This innovative method seeks to bridge the gap between patients and healthcare providers, ensuring continuous support and assessment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with rare diseases who require rehabilitation therapy and can engage with virtual reality technology.
Not a fit: Patients who do not have access to the necessary technology or those who are unable to participate in virtual reality activities may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the accessibility and effectiveness of rehabilitation therapies for patients with rare diseases.
How similar studies have performed: While the use of virtual reality in rehabilitation is gaining traction, this specific application for rare diseases is relatively novel and has not been extensively tested.
Where this research is happening
NATICK, UNITED STATES
- ALTEC, INC. — NATICK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: KLINE, JOSHUA — ALTEC, INC.
- Study coordinator: KLINE, JOSHUA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.